Prenuvo

San Francisco, United States Founded: 2018 • Age: 8 yrs
MRI and screening services are provided for early health detection.

About Prenuvo

Prenuvo is a Healthcare company based in San Francisco (United States) founded in 2018 by Andrew Lacy. MRI and screening services are provided for early health detection. Prenuvo has raised $274.96 million across 4 funding rounds from investors including Forerunner Ventures, Left Lane Capital and Felicis Ventures. Its chief executive, as recorded, is Andrew Lacy. Its website prenuvo.com draws about 789 thousand monthly visits. Prenuvo offers products and services including Whole Body Scan, Torso Scan, and Head and Torso Scan. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is PRENUVO, INC. Its competitors include Subtle Medical, Invicro and Cleerly; 3 of its 3 listed competitors have raised funding.

Company details

Prenuvo was founded in 2018 and is headquartered in San Francisco, United States. MRI scans and other screening services are offered in the healthcare sector, with capabilities to identify solid tumors at Stage 1 and more than 500 health conditions. Operations focus on patient convenience through spacious facilities that support relaxation during procedures, contributing to improved health outcomes.

  • Headquarters San Francisco, United States
  • Founders Andrew Lacy
  • Sectors
    Healthcare
  • Website category Health · Health Conditions and Concerns
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website prenuvo.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Prenuvo, Inc.
Key Metrics
  • Total Equity Funding
    $274.96M (USD)

    in 4 rounds

  • Latest Funding Round
    $120M (USD), Series C

    Feb 2025

  • Investors

Products & Services of Prenuvo

Prenuvo offers a comprehensive portfolio of products and services, including Whole Body Scan, Torso Scan, and Head and Torso Scan.

Whole Body Scan
MRI Screening

Comprehensive scan for early detection of tumors and disorders.

Torso Scan
MRI Screening

Focused scan for chest, abdomen, and pelvis health checks.

Head and Torso Scan
MRI Screening

Scan assessing head, neck, and torso for potential issues.

Funding Insights of Prenuvo

Prenuvo has successfully raised a total of $274.96M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $120 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $274.96M
  • Total Rounds 4
  • Last Round Series C β€” $120M
  • First Round $70M

    (Oct 2022)

  • Investors Count 10

All 4 funding rounds of Prenuvo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2025$120MSeries C–Forerunner Ventures
Jun 2024$84.96MSeries B––
–
Oct 2022$70MSeries A–Felicis Ventures
Oct 2022Debt – Conventional––
Valuation history

10 investors in total: 4 institutional and 6 angel.

Investors in Prenuvo

Prenuvo has secured backing from 10 investors, including venture fund and angel investors. Prominent investors backing the company include Forerunner Ventures, Left Lane Capital and Felicis Ventures.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are directed toward tech startups by Forerunner Ventures.
forerunnerventures.comSan Francisco, United States
Investments are directed toward high-growth consumer and internet technology companies.
leftlane.comBrooklyn, United States
Investments in technology startups are made by Felicis Ventures.
felicis.comMenlo Park, United States
Steel Perlot is focused on building and backing transformative platform technologies.
steelperlot.com

Tony Fadell

Inventor of iPod, Nest Labs founder, active angel investor in tech startups
unknown_fe889a23f1624e55a

Timothy A. Springer

unknown_5e26e3f0297b4d24b

Anne Wojcicki

Co-founder of 23andMe, prominent angel investor in health tech.
unknown_7952b17cd8f4493ab

Eric Schmidt

Former Google CEO, angel investor, tech visionary supporting Indian startups
unknown_5e2a23246f7e45e1a

Rande Gerber

American entrepreneur, angel investor, known for nightlife and tequila ventures.
unknown_b248925cc9bb488ea

Cindy Crawford

unknown_4cafcff2a97b46f29
Premium access

Investor details for Prenuvo

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Prenuvo

61 people are tracked at Prenuvo (21 in leadership, 40 in team).

NameRoleGroup
Andrew Lacy
Founder & CEOLeadership
Daniel J. Durand
Chief Medical OfficerLeadership
Steffen Baumann
Director Of AI Medical Device ProgramsLeadership
V X.
Senior People Business PartnerLeadership
Craig Tomsett
Chief Of Staff / Director Of StrategyLeadership
Emily Backman
General Manager & Clinic DirectorLeadership
Jinu Thomas
General Manager & Center DirectorLeadership
Nicholas Mason
Head of ExpansionLeadership
Dave Kelly
Head of ProductLeadership
Sam Hashemi
Head of Artificial IntelligenceLeadership
Doug Sweeny
Chief Business OfficerLeadership
Elina Määttä
Head of Member ExperienceLeadership
Steve Lemon
Chief Product & Technology OfficerLeadership
Raja Haddad
Chief Marketing OfficerLeadership
Kelly Dyer
Head Of Clinical AI And EngineeringLeadership
Kingsley Chan, CPA, CA
Head Of FinanceLeadership
Cecilia Saez
Head Of People & CultureLeadership
Christine A.
Senior Director, Head Of PR & CommunicationsLeadership
Anders Nelson
Vice President Of Security & ITLeadership
Sarah Colson
Director Of Advanced Practice ProvidersLeadership

41 more people are available in the full profile.

Premium access

Complete people profiles for Prenuvo

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Prenuvo

3 dated milestones of Prenuvo across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Prenuvo is founded.
  2. Funding First funding round of $70.0M.
  3. Funding Latest funding round, Series C, of $120.0M.

Competitors of Prenuvo

Prenuvo has 3 listed competitors in our database, 3 of them funded. They include Subtle Medical, Invicro and Cleerly.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
subtlemedical.com2017Palo Alto, United States$18.3M23
AI-driven solutions for medical diagnostic imaging are developed.
invicro.com2008Boston, United States$45.84M308
Provide contract research imaging services and software
cleerlyhealth.com2016Denver, United States$578.48M
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
Premium access

Detailed competitors of Prenuvo

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Prenuvo

The website of Prenuvo (prenuvo.com) receives about 788.8K visits a month and ranks #84,706 among all websites worldwide, #2,419 in Health Conditions and Concerns.

  • Monthly visits
    788.8K

    ▲ 35.8% vs previous month

  • Unique visitors
    337.3K

    per month

  • Global rank
    #84,706

    among all websites

  • Category rank
    #2,419

    Health · Health Conditions and Concerns

Similar websites

Websites whose visitors overlap most with Prenuvo. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
simonone.com
simonone.com
100%
#1,378,782–
yourattentionplease.com
yourattentionplease.com
97%
#731,243–
breastcancer.org
breastcancer.org
95%
#118,297–
galleri.com
galleri.com
95%
#436,824–
onetestforcancer.com
94%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Prenuvo

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Prenuvo (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Prenuvo

Premium access

Complete news archive for Prenuvo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prenuvo

Prenuvo was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Prenuvo is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Andrew Lacy is the CEO of Prenuvo, as recorded in our data. They have also founded this company.

Prenuvo is a funded company, having raised a total of $274.96M across 4 funding rounds to date. The company's 1st funding round was a Series A of $70M, raised on Oct 2022.

Prenuvo was founded in 2018 and is headquartered in San Francisco, United States. MRI scans and other screening services are offered in the healthcare sector, with capabilities to identify solid tumors at Stage 1 and more than 500 health conditions. Operations focus on patient convenience through spacious facilities that support relaxation during procedures, contributing to improved health outcomes.

Prenuvo's top competitors include Subtle Medical, Cleerly and Invicro.

Prenuvo offers Whole Body Scan, Torso Scan, and Head and Torso Scan.

Prenuvo has 10 investors. Key investors include Forerunner Ventures, Left Lane Capital, Felicis Ventures, Tony Fadell, and Timothy A. Springer.

Prenuvo operates through Prenuvo, Inc..

The website of Prenuvo receives about 789 thousand visits a month and ranks #84,706 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available